Spearhead Capital Advisors’s Guardant Health GH Stock Holding History

Spearhead Capital Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,350	Closed	-$222K	–	191
2022 Q1	$222K	Buy	3,350 +392	+13%	+$26.8K	0.03%	181
2021 Q4	$296K	Buy	2,958 +46	+2%	+$4.76K	0.04%	147
2021 Q3	$364K	Sell	2,912 -13	-0.4%	-$1.54K	0.05%	132
2021 Q2	$363K	Buy	2,925 +322	+12%	+$43.3K	0.05%	159
2021 Q1	$397K	Buy	+2,603	New	+$393K	0.06%	98

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Spearhead Capital Advisors's GH Position: Q2 2022 in Review

Spearhead Capital Advisors sold out of Guardant Health (GH) in Q2 2022, closing a stake of 3,350 shares — an estimated $222K sold.

Spearhead Capital Advisors first reported a position in GH in Q1 2021 and held it in 5 quarters. The position peaked at $397K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Spearhead Capital Advisors reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Spearhead Capital Advisors sold 3,350 Guardant Health shares in Q2 2022, an estimated $222K.
Spearhead Capital Advisors first reported a position in Guardant Health in Q1 2021 and held it in 5 quarters.
Spearhead Capital Advisors's Guardant Health position peaked at $397K in Q1 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Spearhead Capital Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.